Perirectal surveillance cultures and a stool culture grew Aeromonas species from three patients over a 6-week period and were without epidemiological links. Detection of the bla KPC-2 gene in one isolate prompted inclusion of non-Enterobacteriaceae in our surveillance culture workup. Whole-genome sequencing confirmed that the isolates were unrelated and provided data for Aeromonas reference genomes.A eromonas species are Gram-negative environmental bacteria that can cause infections in both immunocompetent and immunocompromised persons (1, 2) and have been isolated from a wide range of aquatic environments, including marine ecosystems, freshwater, hospital effluent, and drinking water (1,(3)(4)(5)(6). The global rise of multidrug-resistant bacteria raises concern that a ubiquitous organism, such as an Aeromonas sp., could acquire antibiotic resistance genes derived from human isolates (3,4, 7, 8). A variety of antibiotic resistance phenotypes, including carbapenem resistance (3, 4, 9-15), have been found in both clinical and environmental Aeromonas isolates. Although rare, clinical Aeromonas isolates containing bla KPC genes have been reported (16, 17).Active microbial surveillance for multidrug-resistant Gramnegative organisms is integral to inpatient care at the NIH Clinical Center. Perirectal swabs are collected upon hospital admission, twice weekly in the intensive care unit, and monthly from all inpatients (excluding those in behavioral health wards). Perirectal swabs were inoculated onto HardyCHROM CRE (Hardy Diagnostics, Santa Maria, CA) and incubated at 35°C ambient air for 18 to 24 h. Isolates were identified using matrixassisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), and isolates belonging to Enterobacteriaceae underwent PCR for detection of bla KPC and bla NDM-1 . Stool specimens were plated onto sheep blood, MacConkey, and xylose lysine deoxycholate agars with incubation at 35°C and 5% CO 2 for 48 h, and on Campy CVA agar with incubation at 42°C under microaerophilic conditions. Results from the surveillance cultures that suggest possible nosocomial acquisition of carbapenemase-producing bacteria trigger epidemiological investigations, including environmental sampling.Perirectal surveillance cultures from two hospitalized adult patients and a stool culture from a third patient grew Aeromonas spp. within a 6-week period. The stool culture isolate (from patient A) was resistant to ertapenem and susceptible to imipenem and meropenem; the perirectal isolates (from patients B and C) were resistant to all three carbapenems. MALDI-TOF MS could not reliably identify the isolates to the species level. On average, clinical Aeromonas spp. had been isolated from clinical cultures in only four to five patients per year in our institution since 2010; this was the first time that Aeromonas had been isolated from perirectal surveillance cultures since they were introduced in 2011. This apparent cluster of Aeromonas colonization prompted an investigation. A patient trace (TheraDo...